MA22905A1 - Nouvelles sequences d'adn . - Google Patents

Nouvelles sequences d'adn .

Info

Publication number
MA22905A1
MA22905A1 MA23204A MA23204A MA22905A1 MA 22905 A1 MA22905 A1 MA 22905A1 MA 23204 A MA23204 A MA 23204A MA 23204 A MA23204 A MA 23204A MA 22905 A1 MA22905 A1 MA 22905A1
Authority
MA
Morocco
Prior art keywords
dna sequences
new dna
new
sequences
dna
Prior art date
Application number
MA23204A
Other languages
English (en)
Inventor
Curt Sven Magnns Enerback
Nilsson
Karl Gunnar Bjurseli
Peter Nils Ivar Carlsson
Torneli
Hansson
Liberg
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE9201809A external-priority patent/SE9201809D0/xx
Priority claimed from SE9201826A external-priority patent/SE9201826D0/xx
Priority claimed from SE9202088A external-priority patent/SE9202088D0/xx
Priority claimed from SE9300902A external-priority patent/SE9300902D0/xx
Application filed by Astra Ab filed Critical Astra Ab
Publication of MA22905A1 publication Critical patent/MA22905A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/8509—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New breeds of animals
    • A01K67/027—New breeds of vertebrates
    • A01K67/0275—Genetically modified vertebrates, e.g. transgenic
    • A01K67/0278—Humanized animals, e.g. knockin
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/20—Dietetic milk products not covered by groups A23C9/12 - A23C9/18
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/18—Carboxylic ester hydrolases (3.1.1)
    • C12N9/20—Triglyceride splitting, e.g. by means of lipase
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2207/00—Modified animals
    • A01K2207/15—Humanized animals
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00—Animals characterised by species
    • A01K2227/10—Mammal
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00—Animals characterised by species
    • A01K2227/10—Mammal
    • A01K2227/105—Murine
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/01—Animal expressing industrially exogenous proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/008—Vector systems having a special element relevant for transcription cell type or tissue specific enhancer/promoter combination
MA23204A 1992-06-11 1993-06-09 Nouvelles sequences d'adn . MA22905A1 (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
SE9201809A SE9201809D0 (sv) 1992-06-11 1992-06-11 New dna sequences
SE9201826A SE9201826D0 (sv) 1992-06-12 1992-06-12 New dna sequences ii
SE9202088A SE9202088D0 (sv) 1992-07-03 1992-07-03 New dna sequences iii
SE9300902A SE9300902D0 (sv) 1993-03-19 1993-03-19 New dna sequences iv

Publications (1)

Publication Number Publication Date
MA22905A1 true MA22905A1 (fr) 1993-12-31

Family

ID=27484751

Family Applications (1)

Application Number Title Priority Date Filing Date
MA23204A MA22905A1 (fr) 1992-06-11 1993-06-09 Nouvelles sequences d'adn .

Country Status (31)

Country Link
US (2) US5616483A (fr)
EP (1) EP0651793B1 (fr)
JP (1) JP4231105B2 (fr)
KR (1) KR100357670B1 (fr)
CN (1) CN1071791C (fr)
AP (1) AP411A (fr)
AT (1) ATE447012T1 (fr)
AU (1) AU670598B2 (fr)
CA (1) CA2137815C (fr)
CZ (1) CZ288677B6 (fr)
DE (1) DE69334298D1 (fr)
DK (1) DK0651793T3 (fr)
ES (1) ES2335626T3 (fr)
FI (1) FI945793A (fr)
HR (1) HRP930935A2 (fr)
HU (1) HU220338B (fr)
IL (1) IL105874A (fr)
IS (1) IS4029A (fr)
MA (1) MA22905A1 (fr)
MX (1) MX9303439A (fr)
NO (1) NO944715L (fr)
NZ (1) NZ253391A (fr)
PH (1) PH31680A (fr)
PT (1) PT651793E (fr)
RU (1) RU2128708C1 (fr)
SG (1) SG52580A1 (fr)
SI (1) SI9300319A (fr)
SK (1) SK286993B6 (fr)
TN (1) TNSN93067A1 (fr)
UA (1) UA41322C2 (fr)
WO (1) WO1993025669A1 (fr)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH09509848A (ja) * 1994-03-09 1997-10-07 アボツト・ラボラトリーズ オリゴ糖及び複合糖質を産生するトランスジェニック動物
US5907080A (en) * 1995-11-30 1999-05-25 Nexia Biotechnologies, Inc. Method for development of transgenic dwarf goats
US7008776B1 (en) * 1996-12-06 2006-03-07 Aventis Pharmaceuticals Inc. Compositions and methods for effecting the levels of high density lipoprotein (HDL) cholesterol and apolipoprotein AI very low density lipoprotein (VLDL) cholesterol and low density lipoprotein (LDL) cholesterol
PL191624B1 (pl) * 1996-12-06 2006-06-30 Aventis Pharma Inc Wyizolowany polipeptyd kodowany przez gen białka podobnego do lipazy, jego fragment antygenowy, wyizolowany kwas nukleinowy kodujący ten polipeptyd i wektor go zawierający, zrekombinowana komórka zawierająca ten wektor, sposób wytwarzania polipeptydu, przeciwciało zdolne do wiązania polipeptydu i komórka hybrydomy je wytwarzająca, kompozycja farmaceutyczna, sposób wyszukiwania agonistów lub antagonistów aktywności polipeptydu, sposób enzymatycznej hydrolizy in vitro estru fosfatydylocholiny, zastosowanie polipeptydu oraz transgeniczna mysz
FR2763958A1 (fr) * 1997-05-29 1998-12-04 Transgene Sa Produit de combinaison associant un acide nucleique a une substance desorganisant la matrice extracellulaire pour la therapie genique
US20040213789A1 (en) * 1997-09-02 2004-10-28 Oron Yacoby-Zeevi Heparanase activity neutralizing anti-heparanase monoclonal antibody and other anti-heparanase antibodies
US6177545B1 (en) * 1997-09-02 2001-01-23 Insight Strategy & Marketing Ltd. Heparanase specific molecular probes and their use in research and medical applications
US20010006630A1 (en) * 1997-09-02 2001-07-05 Oron Yacoby-Zeevi Introducing a biological material into a patient
US20020088019A1 (en) * 1997-09-02 2002-07-04 Oron Yacoby-Zeevi Methods of and pharmaceutical compositions for improving implantation of embryos
US6699672B1 (en) * 1997-09-02 2004-03-02 Insight Biopharmaceuticals Ltd. Heparanase specific molecular probes and their use research and medical applications
SE9801424D0 (sv) * 1998-04-22 1998-04-22 Astra Ab Expression methods
US20030217375A1 (en) * 1998-08-31 2003-11-20 Eyal Zcharia Transgenic animals expressing heparanase and uses thereof
EP1157118A4 (fr) * 1999-03-01 2002-07-17 Insight Strategy & Marketing Polynucleotide codant pour un polypeptide ayant une activite d'heparanase et expression de ce polynucleotide dans des cellules genetiquement modifiees
JP2003530067A (ja) * 1999-04-09 2003-10-14 ヒューマン ジノーム サイエンシーズ， インコーポレイテッド ４９個のヒト分泌タンパク質
AU5032600A (en) * 1999-05-19 2001-12-03 Barnes-Jewish Hospital Enhanced triglyceride digestion in a deficiency of bile salts
JP2004527210A (ja) 2000-08-02 2004-09-09 ザ ジョンズ ホプキンス ユニバーシティー 内皮細胞発現パターンの評価法
IT1319655B1 (it) 2000-11-15 2003-10-23 Eurand Int Microsfere di enzimi pancreatici con elevata stabilita' e relativometodo di preparazione.
US20020182243A1 (en) * 2001-05-14 2002-12-05 Medo Elena Maria Method of producing nutritional products from human milk tissue and compositions thereof
US20100268658A1 (en) * 2001-05-14 2010-10-21 Prolacta Bioscience Method for collecting, testing and distributing milk
US6671189B2 (en) * 2001-11-09 2003-12-30 Minebea Co., Ltd. Power converter having primary and secondary side switches
US20030213007A1 (en) * 2002-03-27 2003-11-13 Slattery Charles Wilbur Human milk produced by human mammary tissue implanted in non-human host animals and uses thereof
WO2004108065A2 (fr) * 2003-06-09 2004-12-16 Insight Biopharmaceuticals Ltd. Activite d'heparanase neutralisant un anticorps monoclonal anti-heparanase et d'autres anticorps anti-heparanase
WO2007035870A2 (fr) * 2005-09-20 2007-03-29 Prolacta Bioscience, Inc. Méthode pour analyser le lait
WO2007089133A1 (fr) * 2006-02-03 2007-08-09 Academisch Medisch Centrum Bij De Universiteit Van Amsterdam Moyens et procédés permettant d'influencer des interactions entre la dc-sign et des ligands de dc-sign
CN105123950A (zh) * 2006-11-29 2015-12-09 普罗莱克塔生物科学公司 人乳组合物及其制备和使用方法
US8377445B2 (en) * 2006-12-08 2013-02-19 Prolacta Bioscience, Inc. Compositions of human lipids and methods of making and using same
PT2079445E (pt) 2007-02-20 2016-02-29 Allergan Pharmaceuticals Internat Ltd Composições de enzimas digestivas estáveis
WO2009109856A2 (fr) 2008-03-07 2009-09-11 Axcan Pharma Inc. Procédé pour détecter un parvovirus infectieux dans des préparations pharmaceutiques
CN102300575A (zh) 2008-12-02 2011-12-28 普罗莱克塔生物科学公司 人乳渗透物组合物及其制备和使用方法
ES2657673T3 (es) 2010-10-01 2018-03-06 Aptalis Pharma Limited Formulaciones recubiertas entéricas de pancrelipasa, de baja intensidad
WO2012052059A1 (fr) * 2010-10-21 2012-04-26 Swedish Orphan Biovitrum Ab (Publ) Procédé pour augmenter l'absorption d'acides gras insaturés par des nourrissons humains
CN103200957A (zh) * 2010-10-21 2013-07-10 瑞典孤儿比奥维特鲁姆有限公司 提高人婴儿之生长速度的方法
PL2739157T3 (pl) 2011-08-03 2018-03-30 Prolacta Bioscience, Inc. Mikrofiltracja ludzkiego mleka dla redukcji zanieczyszczenia bakteryjnego
RU2602183C2 (ru) 2011-08-08 2016-11-10 Апталис Фарма Лтд. Способ проведения теста на растворение твердых композиций, содержащих пищеварительные ферменты
CN103088000A (zh) * 2012-03-23 2013-05-08 北京济福霖生物技术有限公司 在哺乳动物乳腺中过表达胆盐激活脂酶的方法
EP2852668B1 (fr) * 2012-07-12 2016-04-27 ProQR Therapeutics II B.V. Oligonucléotides pour introduire une modification dans la séquence d'une molécule d'arn cible présente dans une cellule vivante
WO2014158911A1 (fr) 2013-03-13 2014-10-02 Prolacta Bioscience Produits à base de lait maternel à forte teneur lipidique
JP2016537387A (ja) 2013-08-09 2016-12-01 アラガン ファーマシューティカルズ インターナショナル リミテッド 経腸投与に適した消化酵素組成物
CA2947998A1 (fr) 2014-06-19 2015-12-23 Aptalis Pharma Ltd. Procedes d'elimination de contaminants viraux dans des extraits pancreatiques
US11344041B2 (en) 2015-12-30 2022-05-31 Prolacta Bioscience, Inc. Human milk products useful in pre- and post-operative care

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3256150A (en) * 1964-04-20 1966-06-14 Dairyland Food Lab Method for treating malabsorption syndrome
GB1509866A (en) * 1975-06-10 1978-05-04 Johnson & Johnson Enteric coated digestive enzyme compositions
US4873316A (en) * 1987-06-23 1989-10-10 Biogen, Inc. Isolation of exogenous recombinant proteins from the milk of transgenic mammals
US5200183A (en) * 1987-11-19 1993-04-06 Oklahoma Medical Research Foundation Recombinant bile salt activated lipases
US4944944A (en) * 1987-11-19 1990-07-31 Oklahoma Medical Research Foundation Dietary compositions and methods using bile salt-activated lipase
US5173408A (en) * 1989-11-13 1992-12-22 Lange Louis George Iii Mammalian pancreatic cholesterol esterase
WO1991015534A1 (fr) * 1990-03-30 1991-10-17 Allied-Signal Inc. Poly(vinylenes aromatiques) et poly (vinylenes heteoaromatiques) electroconducteurs
SE9001985D0 (sv) * 1990-06-01 1990-06-01 Astra Ab New chemical products

Also Published As

Publication number Publication date
PH31680A (en) 1999-01-18
AU670598B2 (en) 1996-07-25
HRP930935A2 (en) 1994-12-31
FI945793A0 (fi) 1994-12-09
UA41322C2 (uk) 2001-09-17
EP0651793B1 (fr) 2009-10-28
HUT71789A (en) 1996-02-28
US5616483A (en) 1997-04-01
AP9300538A0 (en) 1993-07-31
ES2335626T3 (es) 2010-03-30
CN1086262A (zh) 1994-05-04
JPH07507687A (ja) 1995-08-31
NZ253391A (en) 1996-01-26
ATE447012T1 (de) 2009-11-15
CN1071791C (zh) 2001-09-26
AU4366793A (en) 1994-01-04
NO944715D0 (no) 1994-12-07
JP4231105B2 (ja) 2009-02-25
SI9300319A (en) 1994-03-31
KR100357670B1 (ko) 2003-04-11
HU220338B (hu) 2001-12-28
MX9303439A (es) 1994-04-29
PT651793E (pt) 2010-01-20
AP411A (en) 1995-09-28
HU9403536D0 (en) 1995-02-28
RU2128708C1 (ru) 1999-04-10
SK148694A3 (en) 1995-08-09
CA2137815C (fr) 2010-11-09
TNSN93067A1 (fr) 1994-03-17
NO944715L (no) 1995-02-07
EP0651793A1 (fr) 1995-05-10
CA2137815A1 (fr) 1993-12-23
WO1993025669A1 (fr) 1993-12-23
SK286993B6 (sk) 2009-09-07
DK0651793T3 (da) 2010-03-15
FI945793A (fi) 1995-02-09
SG52580A1 (en) 1998-09-28
IL105874A (en) 1998-12-27
RU94046360A (ru) 1997-06-10
DE69334298D1 (de) 2009-12-10
CZ309194A3 (en) 1995-07-12
US5716817A (en) 1998-02-10
CZ288677B6 (cs) 2001-08-15
IL105874A0 (en) 1993-10-20
IS4029A (is) 1993-12-12

Similar Documents

Publication Publication Date Title
MA22905A1 (fr) Nouvelles sequences d'adn .
FI924188A0 (fi) Platsspecifik spjaelkning av en enkelstraengad dna.
FI883596A0 (fi) Epipodofyllotoxinglukosid-4' -fosfatderivat.
DZ1835A1 (fr) Nouvelles formulations.
NO964628D0 (no) DNA-sekvenser
MX9205172A (es) Genes de pinosilvinsintasa.
DE3576524D1 (de) Dna-sequenzen.
FI923911A0 (fi) Dna-molekylers in vitro-syntes.
NO913814D0 (no) Innskudd av dna med modifiserte transposoner.
NO932842D0 (no) 1,4-benzodioksanderivater
DZ1781A1 (fr) Agents d'arylation.
DE59308564D1 (de) 2,4-Dialkyl-6-sec-alkylphenole
FI915455A0 (fi) Metallurgisk ugninstallation.
FR2610625B1 (fr) 2-oxo-4-(2'-difluoromethylthiophenyl)5-methoxycarbonyl-6-methyl-1,2,3,4-tetrahydropyrimidine
NO883857L (no) 3'-demetoksyepipodofyllotoksin-glukosidderivater.
FI885785A0 (fi) Epipodofyllotoxinglukosid-4' -acylderivat.
FR2674253B1 (fr) Composition lyophilisee pour la multiplication de sequences d'acides nucleiques.
DE625642T1 (de) Mantelgebläse.
DE3778970D1 (de) Benzenoxygenase-gen.
IT8920827A0 (it) Sequenze di nucleotidi.
FR2724962B3 (fr) Tuile d'avant-toit sous-faitiere.
DE69730411D1 (de) Metastasen induzierende dna's
FR2673953B1 (fr) Procede de sequencage non radioactif d'adn.
FR2696608B1 (fr) Publiphone.
SE9201809D0 (sv) New dna sequences